Li Lei, Zhao Lian-Mei, Dai Su-Li, Cui Wen-Xuan, Lv Hui-Lai, Chen Liang, Shan Bao-En
Cell Physiol Biochem. 2016;38(5):1939-51. doi: 10.1159/000445555. Epub 2016 May 9.
BACKGROUND/AIMS: Periplocin is extracted from the traditional herbal medicine cortex periplocae, which has been reported to suppress the growth of cancer cells. However, little is known about its effect on gastric cancer cells.
Gastric cancer cells were treated with periplocin, and cell viability was assessed using MTS assay. Flow cytometry and TUNEL staining were performed to evaluate apoptosis, and protein expression was examined by western blotting. Microarray analysis was used to screen for changes in related genes.
We found that periplocin had an inhibitory effect on gastric cancer cell viability in a dose-dependent manner. Periplocin inhibited cell viability via the ERK1/2-EGR1 pathway to induce apoptosis. Periplocin also inhibited the growth of tumor xenografts and induced apoptosis in vivo.
Our results show that periplocin inhibits the proliferation of gastric cancer cells and induces apoptosis in vitro and in vivo, indicating its potential to be used as an antitumor drug.
背景/目的:香加皮苷是从传统草药香加皮中提取的,据报道其具有抑制癌细胞生长的作用。然而,关于其对胃癌细胞的影响知之甚少。
用香加皮苷处理胃癌细胞,采用MTS法评估细胞活力。进行流式细胞术和TUNEL染色以评估细胞凋亡,并通过蛋白质印迹法检测蛋白质表达。利用基因芯片分析筛选相关基因的变化。
我们发现香加皮苷对胃癌细胞活力具有剂量依赖性抑制作用。香加皮苷通过ERK1/2-EGR1途径抑制细胞活力以诱导凋亡。香加皮苷还抑制体内肿瘤异种移植的生长并诱导凋亡。
我们的结果表明,香加皮苷在体外和体内均能抑制胃癌细胞增殖并诱导凋亡,表明其具有作为抗肿瘤药物的潜力。